TINY HONG KONG is now the second largest biotech fundraising hub in the world. By far the largest in Asia, it is second only to New York in raising funds for health-related companies.
The southern Chinese city has been moving up the scale since a dramatic stock market reform in 2018 allowed biotech firms…
